耐热粉末铝合金筒体热旋成形试验

介绍了喷射沉积耐热铝合金管坯经挤压变形 ,变薄旋压筒体的研制过程 ;重点论述了热旋成形筒体的工艺路线。试验探讨了耐热铝合金的旋压温度为 35 0～ 45 0℃ ,道次变薄率约为2 0 % ,累计变薄率约 5 0 % ,需中间退火 ,退火温度宜取 35 0℃。热旋结果认为 ,喷射沉积耐热粉末铝合金铸坯直接热旋成形困难 ,需经挤压比大于 4的变形致密 ,有助于热旋成形。耐热粉末铝合金挤压坯加热变薄旋压 ,应采用小压下量多道次的变形过程 ,逐渐细化晶粒组织 ,才能旋出综合性能良好的筒形件。     

上海市大气颗粒物高浓度区污染物的源解析

应用受体模式的化学质量平衡法支９个监测点的大气颗粒物进行污染源的源解析，得出这９个监测点的各类污染源平均贡献率为建筑尘占３２．１％，土壤尘占２７．５％，钢铁尘占２４．９％，燃煤尘占１４．８％，汽车尘和燃油尘分别占０．２％和０．４％。     

炼油污水气浮絮凝处理中试

气浮絮凝是炼油污水处理工艺中重要的一步 ,它是确保炼油污水生化处理顺利运行的关键 ,而开发和筛选优良的絮凝剂则又是提高气浮处理效果的保证。采用无机—有机复合絮凝剂进行炼油污水的中试试验 ,通过一系列条件试验 ,确定了复合絮凝剂投药剂量、投药间隔时间和投药方式 ,取得了令人满意的试验效果 ,CODCr的去除率 5 5 % ,石油类去除率 >75 % ,为后续的生化处理提供了合格的水质     

Analysis of the Henze precipitate from the blood cells of the ascidian<Emphasis Type="Italic"> Phallusia mammillata</Emphasis>

The Henze precipitate, a peculiar blue-green microparticulate obtained by lysis of the blood cells of the ascidian Phallusia mammillata (Protochordata), was investigated with atomic force microscopy (AFM), scanning electron microscopy (SEM) and X-ray microanalysis. The precipitate was collected from the Henze solution, an unstable red-brown product obtained by treating blood with distilled water, whose degradation yields a characteristic blue-green product. The microparticulates measured 50–100 µm in diameter and appeared irregular in shape. SEM examination showed smooth, roughly round boundaries. The microparticulate surface examined with AFM appeared as an irregular matrix formed by 70–320-nm-wide mammillate composites, including and embedding small (500–800 nm wide) crystal-like multilayered formations. X- ray analysis showed that the elements present in these same precipitates were mainly C, Si, Al and O. The microparticulate composition appeared close to those of natural waxes or lacquers, embedding amorphous silicates and/or other Si–Al components. The unusual occurrence of Si in ascidian blood and its role are discussed.     

公路设计中的环境保护工作

阐述了公路建设中环境保护工作的意义，提出在公路工程勘察设计工作中对环境保护的典型作法和取得的效果。     

Reproductive behaviour and prenatal diagnosis following genetic termination of pregnancy in women of advanced maternal age

One hundred and fifty-one women of advanced maternal age who underwent genetic termination of pregnancy (TOP) were studied for their reproductive behaviour and the type of procedure for prenatal diagnosis in a subsequent pregnancy. A total of 59 women (39 per cent) had a further pregnancy. In all continuing pregnancies prenatal diagnosis was performed, of which 75 per cent consisted of chorionic villus sampling (CVS). Reproductive behaviour following a genetic termination was negatively correlated with maternal age and parity. Both reproductive behaviour and the choice to undergo a diagnostic procedure in the next pregnancy were independent of the type of diagnostic procedure in the previous affected pregnancy.     

Prenatal diagnosis in two cases of de novo complex balanced chromosomal rearrangements. Three-year follow-up in one case

We report two cases of apparently balanced complex de novo chromosomal rearrangements (BCCR) detected prenatally at 17 weeks and 10 weeks of gestation, respectively. Chromosomes were studied using GTG-banding and fluorescent in situ hybridization (FISH). In one case four chromosomes and in the other case three chromosomes were involved in the rearrangements. One of the pregnancies was terminated and no external or internal abnormalities were detected at autopsy. The other pregnancy continued to term. Level III ultrasound examination showed no abnormalities. The child is now 3 years old and has neither congenital anomalies nor evidence of delayed psychomotor development.     

A Framework for Monitoring and Evaluating Carbon Mitigation by Farm Forestry Projects: Example of a Demonstration Project in Chiapas,Mexico

Mitigation and Adaptation Strategies for Global Change - In Mexico an estimated 4.5 × 106ha are available for farm forestry, while up to 6.1 × 106 ha could be saved from deforestation by...     

Second-trimester cancer antigen 125 and Down's syndrome

This study explores if assay of cancer antigen 125 (CA 125) in maternal serum might aid the detection of Down's syndrome in the second trimester of pregnancy. CA 125 levels were determined retrospectively in stored maternal serum samples from ten Down's syndrome pregnancies and 78 controls matched for gestational and maternal age. In addition, second-trimester amniotic fluid samples from nine Down's syndrome and 109 unaffected pregnancies were analysed for CA 125. Maternal serum CA 125 values for Down's syndrome pregnancies were lower, with the median being 0.72 multiples of the unaffected population median. The medians for affected and unaffected pregnancies did not differ significantly and there was a considerable overlap in the range of values of cases and controls. The distribution of amniotic fluid CA 125 levels for Down's syndrome pregnancies resembled that for controls. From our present results, we could not find an association between Down's syndrome and second-trimester maternal serum or amniotic fluid CA 125 levels.